Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Catalyst Biosciences Inc is a clinical-stage biopharmaceutical company. It mainly focuses on developing novel medicines to address serious medical conditions for individuals in need of treatment options. The company emphasizes product development efforts in the field of hemostasis and to develop val... Catalyst Biosciences Inc is a clinical-stage biopharmaceutical company. It mainly focuses on developing novel medicines to address serious medical conditions for individuals in need of treatment options. The company emphasizes product development efforts in the field of hemostasis and to develop valuable therapies for individuals with hemophilia. It is engaged in the clinical development of improved, next-generation subcutaneous prophylaxis using enhanced potency Factor VIIa and Factor IX variants. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.92 | 8.57409133271 | 10.73 | 11.85 | 10.5 | 65099 | 11.44202921 | CS |
| 4 | -0.54 | -4.42986054143 | 12.19 | 12.3 | 9.51 | 103430 | 10.45585465 | CS |
| 12 | -3.23 | -21.7069892473 | 14.88 | 19 | 9.51 | 114129 | 11.41256761 | CS |
| 26 | -2.61 | -18.3029453015 | 14.26 | 19 | 8.26 | 77124 | 11.95815752 | CS |
| 52 | -2.85 | -19.6551724138 | 14.5 | 26.37 | 8.26 | 75136 | 13.33323504 | CS |
| 156 | 4.65 | 66.4285714286 | 7 | 30.4 | 5.88 | 82781 | 15.17829314 | CS |
| 260 | 4.65 | 66.4285714286 | 7 | 30.4 | 5.88 | 82781 | 15.17829314 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
